Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma, Novel Agents

Umesh Bhatt

MD

🏢Ohio State University🌐USA

Medical Oncologist

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Umesh Bhatt at Ohio State contributes to follicular lymphoma clinical research, including the development of PI3K delta inhibitor approaches (copanlisib, idelalisib) for relapsed follicular lymphoma. His work on follicular lymphoma therapy sequencing and on risk stratification using FLIPI and molecular factors addresses the challenge of optimizing treatment selection in this incurable but manageable lymphoma.

Share:

🧪Research Fields 研究领域

follicular lymphoma treatment
PI3K inhibitors lymphoma
copanlisib follicular
obinutuzumab follicular
grade 3B follicular lymphoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Umesh Bhatt 的研究动态

Follow Umesh Bhatt's research updates

留下邮箱,当我们发布与 Umesh Bhatt(Ohio State University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment